Think Media Solutions – Helping Brands AttrⒶℂ, Convert, and Retain Customers qwikad.com/showad.php?pos… August 29, 2025 #think #media #solutions #helping #brands #attr #convert #retain #customers

This weekend, members from our #ATTR team will be at the #ESCCongress. HCPs: Don’t miss our symposium on Monday, chaired by Dr. Julian Gillmore, discussing all things #amyloidosis and advancements in the field. #ESCCongress #WCCardio

Seguimos con las presentaciones de IMedCV Hospital Italiano en este jueves de #ESCcongress 🇪🇺 Con Pilar Domenech mostramos dos de nuestros trabajos en #ATTR-CM 👏

Full house at the #ATTR session #ESC25 #ESC2025 #CardioTwitter

Rethinking 99mTc-DPD scintigraphy for treatment response in #ATTR-CM? In this retrospective study, reduction in tracer was poorly correlated with established markers of response, including ECV, proBNP & #LVEF. jacc.org/doi/10.1016/j.… #JACCIMG AldostefanoPorcari Rishi Patel

An Experiment in Writing – Part 46: Attribution via Action (and a little bit more) #togetherwerise josephcarrabis.com/2025/08/27/an-… #attr #Character #Dialogue #Plot

Only one hour until our spotlight poster at #ISPEAnnual2025! Implementing and Validating an Algorithm for Identifying ATTR-CM patients in the PHARMO Data Network (Poster SLC-037) presented by Eleonora Iob, PhD, 12:15-1:15pm #ATTR #Amyloidosis #Epidemiology #Pharmacoepidemiology

UAB CardioVascular Research Mayo Clinic Proceedings More great work from 1st Annual #ATTR Early-Career Research Forum participants! Way to go, Dr. Nirav Patel!

Exciting progress in diagnosing and treating transthyretin amyloidosis (ATTR) brings new hope to patients! Learn about the latest advances in early detection and innovative therapies. #ATTR #MedicalBreakthroughs #HealthNews articleoutline.com/latest-advance…

Remember to join us Sunday, September 14, at 3:30 PM EDT, for our #ATTRvPN live in-person & virtual symposium. Please tweet your questions in advance and follow PeerView for more #MedEd content! bit.ly/ATTR25T #ANA2025 #ATTR #amyloidosis

Viet Le DMSc PA-C FACC FAHA HF-Cert Richard Ferraro CardioNerds Justin L. Grodin Thanks for the shoutout and for listening to us Viet Le DMSc PA-C FACC FAHA HF-Cert!!! It was so fun working with Justin L. Grodin and Richard Ferraro - & it’s an exciting time to learn about #ATTR amyloidosis!! 😎🫀

#東京大学 は、#熊本大学、#筑波大学、#京都大学、#和歌山県立医科大学、#富山大学 の研究グループと共同で、難病「#トランスサイレチンアミロイドーシス（#ATTR）」に対し、新たな治療戦略を打ち出したと発表しました。 raresnet.com/250818-01/

An upcoming observational study will assess phenotypic variables in asymptomatic patients carrying the #Val50Met variant, which is associated with hereditary #ATTR that can manifest as #ATTRPN. Learn more: bit.ly/45rYui8 #RareDisease #MedTwitter

We are talking about amyloidosis today with cardiology, pathology, neurology and heme-onc colleagues! Rutgers Cancer Institute RWJBarnabas #ALAmyloid #ATTR

Join us 9/18 for Cardio Connections: Guidelines, Gadgets, and Game-changers. This free virtual event will explore critical topics shaping patient care, including #ATTR-CM, #HTNguidelines updates, #LDLC, and #Lpa management. Earn 2.25 CE contact hours: bit.ly/45fs0aU

"We cannot accept a system where only those with means can benefit from life-changing drugs," explained JACC Editor-in-Chief Harlan Krumholz, MD. #cardiacamyloidosis #amyloidosis #ATTR #Cardiology #Pharma ow.ly/cHxI50WEU7p